{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T20:05:47Z","timestamp":1785528347959,"version":"3.56.0"},"reference-count":112,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T00:00:00Z","timestamp":1785369600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T00:00:00Z","timestamp":1785369600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005788","name":"Medical University of Vienna","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005788","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Heart Fail Rev"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Valvular cardiomyopathy has emerged as a key concept linking valvular heart disease (VHD) with myocardial remodeling and the development of heart failure (HF). This state-of-the-art review provides a comprehensive overview of pathophysiological mechanisms, multimodality imaging, and implication for valve interventions across the spectrum of VHD. We systematically address HF in the context of aortic valve disease, including aortic stenosis and aortic regurgitation, mitral valve disease with a particular focus on mitral regurgitation, and tricuspid valve regurgitation. For each valvular lesion, we integrate evidence on pathophysiological mechanisms on myocardial (mal)adaptation leading to myocardial fibrosis and ultimately HF and death. Additionally, we highlight the role of multimodality imaging for early detection of myocardial remodeling and discuss implications for patient selection and timing of valve interventions. Beyond single-valve disease, we further explore the complex interplay of multiple and mixed valvular heart disease and review emerging data on the interaction between VHD and cardiac amyloidosis, an increasingly recognized and clinically relevant overlap. Overall, this state-of-the-art review underscores that outcomes in VHD are not solely determined by severity of valvular lesions but critically depend on the extent of associated myocardial damage. A deeper understanding of valvular cardiomyopathy may improve risk stratification, refine patient selection, and support the implementation of tailored therapeutic strategies.<\/jats:p>","DOI":"10.1007\/s10741-026-10660-0","type":"journal-article","created":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T01:28:20Z","timestamp":1785374900000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Myocardial remodeling in valvular heart disease: pathophysiology, multimodality imaging and treatment implications"],"prefix":"10.1007","volume":"31","author":[{"given":"Maximilian","family":"Autherith","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurenz","family":"Hauptmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raghuram","family":"Palaparti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp E.","family":"Bartko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Nitsche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,30]]},"reference":[{"issue":"44","key":"10660_CR1","doi-asserted-by":"publisher","first-page":"4635","DOI":"10.1093\/eurheartj\/ehaf194","volume":"46","author":"F Praz","year":"2025","unstructured":"Praz F, Borger MA, Lanz J et al (2025) 2025 ESC\/EACTS Guidelines for the management of valvular heart disease. Eur Heart J 46(44):4635\u20134736 (In eng). https:\/\/doi.org\/10.1093\/eurheartj\/ehaf194","journal-title":"Eur Heart J"},{"issue":"5","key":"10660_CR2","doi-asserted-by":"publisher","first-page":"e72","DOI":"10.1161\/cir.0000000000000923","volume":"143","author":"CM Otto","year":"2021","unstructured":"Otto CM, Nishimura RA, Bonow RO et al (2021) 2020 ACC\/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation 143(5):e72\u2013e227 (In eng). https:\/\/doi.org\/10.1161\/cir.0000000000000923","journal-title":"Circulation"},{"issue":"19","key":"10660_CR3","doi-asserted-by":"publisher","first-page":"2263","DOI":"10.1016\/j.jacc.2016.02.057","volume":"67","author":"P G\u00e9n\u00e9reux","year":"2016","unstructured":"G\u00e9n\u00e9reux P, Stone GW, O\u2019Gara PT et al (2016) Natural History, Diagnostic Approaches, and Therapeutic Strategies for Patients With Asymptomatic Severe Aortic Stenosis. J Am Coll Cardiol 67(19):2263\u20132288 (In eng). https:\/\/doi.org\/10.1016\/j.jacc.2016.02.057","journal-title":"J Am Coll Cardiol"},{"issue":"45","key":"10660_CR4","doi-asserted-by":"publisher","first-page":"3351","DOI":"10.1093\/eurheartj\/ehx381","volume":"38","author":"P G\u00e9n\u00e9reux","year":"2017","unstructured":"G\u00e9n\u00e9reux P, Pibarot P, Redfors B et al (2017) Staging classification of aortic stenosis based on the extent of cardiac damage. Eur Heart J 38(45):3351\u20133358 (In eng). https:\/\/doi.org\/10.1093\/eurheartj\/ehx381","journal-title":"Eur Heart J"},{"issue":"12","key":"10660_CR5","doi-asserted-by":"publisher","first-page":"e017425","DOI":"10.1161\/circimaging.124.017425","volume":"17","author":"J Bennett","year":"2024","unstructured":"Bennett J, Thornton GD, Nitsche C et al (2024) Left Ventricular Hypertrophy in Aortic Stenosis: Early Cell and Matrix Regression 2 Months Post-Aortic Valve Replacement. Circ Cardiovasc Imaging 17(12):e017425 (In eng). https:\/\/doi.org\/10.1161\/circimaging.124.017425","journal-title":"Circ Cardiovasc Imaging"},{"issue":"8","key":"10660_CR6","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1093\/eurheartj\/ehx353","volume":"39","author":"TA Treibel","year":"2018","unstructured":"Treibel TA, L\u00f3pez B, Gonz\u00e1lez A et al (2018) Reappraising myocardial fibrosis in severe aortic stenosis: an invasive and non-invasive study in 133 patients. Eur Heart J 39(8):699\u2013709 (In eng). https:\/\/doi.org\/10.1093\/eurheartj\/ehx353","journal-title":"Eur Heart J"},{"issue":"8","key":"10660_CR7","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1016\/j.jacc.2017.12.035","volume":"71","author":"TA Treibel","year":"2018","unstructured":"Treibel TA, Kozor R, Schofield R et al (2018) Reverse Myocardial Remodeling Following Valve Replacement in Patients With Aortic Stenosis. J Am Coll Cardiol 71(8):860\u2013871 (In eng). https:\/\/doi.org\/10.1016\/j.jacc.2017.12.035","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"10660_CR8","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.jcmg.2020.08.010","volume":"14","author":"C Nitsche","year":"2021","unstructured":"Nitsche C, Kammerlander AA, Koschutnik M et al (2021) Volume Status Impacts CMR-Extracellular Volume Measurements and Outcome in AS Undergoing TAVR. JACC Cardiovasc Imaging 14(2):516\u2013518 (In eng). https:\/\/doi.org\/10.1016\/j.jcmg.2020.08.010","journal-title":"JACC Cardiovasc Imaging"},{"issue":"3","key":"10660_CR9","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/j.jacc.2019.11.032","volume":"75","author":"RJ Everett","year":"2020","unstructured":"Everett RJ, Treibel TA, Fukui M et al (2020) Extracellular Myocardial Volume in Patients With Aortic Stenosis. J Am Coll Cardiol 75(3):304\u2013316 (In eng). https:\/\/doi.org\/10.1016\/j.jacc.2019.11.032","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"10660_CR10","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1001\/jama.2024.22730","volume":"333","author":"K Loganath","year":"2025","unstructured":"Loganath K, Craig NJ, Everett RJ et al (2025) Early Intervention in Patients With Asymptomatic Severe Aortic Stenosis and Myocardial Fibrosis: The EVOLVED Randomized Clinical Trial. JAMA 333(3):213\u2013221 (In eng). https:\/\/doi.org\/10.1001\/jama.2024.22730","journal-title":"JAMA"},{"issue":"2","key":"10660_CR11","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.jcmg.2024.08.003","volume":"18","author":"HJ Lee","year":"2025","unstructured":"Lee HJ, Singh A, Lim J et al (2025) Diffuse Interstitial Fibrosis of the Myocardium Predicts Outcome in Moderate and Asymptomatic Severe Aortic Stenosis. JACC Cardiovasc Imaging 18(2):180\u2013191 (In eng). https:\/\/doi.org\/10.1016\/j.jcmg.2024.08.003","journal-title":"JACC Cardiovasc Imaging"},{"issue":"6","key":"10660_CR12","doi-asserted-by":"publisher","first-page":"e007451","DOI":"10.1161\/circimaging.117.007451","volume":"11","author":"RJ Everett","year":"2018","unstructured":"Everett RJ, Tastet L, Clavel MA et al (2018) Progression of Hypertrophy and Myocardial Fibrosis in Aortic Stenosis: A Multicenter Cardiac Magnetic Resonance Study. Circ Cardiovasc Imaging 11(6):e007451 (In eng). https:\/\/doi.org\/10.1161\/circimaging.117.007451","journal-title":"Circ Cardiovasc Imaging"},{"issue":"12","key":"10660_CR13","doi-asserted-by":"publisher","first-page":"2008","DOI":"10.1002\/ejhf.2345","volume":"23","author":"AA Kammerlander","year":"2021","unstructured":"Kammerlander AA, Nitsche C, Don\u00e0 C et al (2021) Heart failure with preserved ejection fraction after left-sided valve surgery: prevalent and relevant. Eur J Heart Fail 23(12):2008\u20132016 (In eng). https:\/\/doi.org\/10.1002\/ejhf.2345","journal-title":"Eur J Heart Fail"},{"issue":"19","key":"10660_CR14","doi-asserted-by":"publisher","first-page":"1854","DOI":"10.1016\/j.jacc.2012.02.093","volume":"60","author":"MR Dweck","year":"2012","unstructured":"Dweck MR, Boon NA, Newby DE (2012) Calcific aortic stenosis: a disease of the valve and the myocardium. J Am Coll Cardiol 60(19):1854\u20131863 (In eng). https:\/\/doi.org\/10.1016\/j.jacc.2012.02.093","journal-title":"J Am Coll Cardiol"},{"issue":"19","key":"10660_CR15","doi-asserted-by":"publisher","first-page":"1854","DOI":"10.1016\/j.jacc.2012.02.093","volume":"60","author":"MR Dweck","year":"2012","unstructured":"Dweck MR, Boon NA, Newby DE (2012) Calcific Aortic Stenosis: A Disease of the Valve and the Myocardium. J Am Coll Cardiol 60(19):1854\u20131863. https:\/\/doi.org\/10.1016\/j.jacc.2012.02.093","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"10660_CR16","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1161\/01.cir.0000051865.66123.b7","volume":"107","author":"S Hein","year":"2003","unstructured":"Hein S, Arnon E, Kostin S et al (2003) Progression from compensated hypertrophy to failure in the pressure-overloaded human heart: structural deterioration and compensatory mechanisms. Circulation 107(7):984\u2013991 (In eng). https:\/\/doi.org\/10.1161\/01.cir.0000051865.66123.b7","journal-title":"Circulation"},{"issue":"12","key":"10660_CR17","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1016\/j.jacc.2011.03.064","volume":"58","author":"MR Dweck","year":"2011","unstructured":"Dweck MR, Joshi S, Murigu T et al (2011) Midwall fibrosis is an independent predictor of mortality in patients with aortic stenosis. J Am Coll Cardiol 58(12):1271\u20131279 (In eng). https:\/\/doi.org\/10.1016\/j.jacc.2011.03.064","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"10660_CR18","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1016\/j.jcmg.2024.03.008","volume":"17","author":"GD Thornton","year":"2024","unstructured":"Thornton GD, Bennett JB, Nitsche C et al (2024) Myocardial Hypoperfusion in Severe Aortic Stenosis Is Reversed Early After Aortic Valve Replacement. JACC Cardiovasc Imaging 17(8):1006\u20131008 (In eng). https:\/\/doi.org\/10.1016\/j.jcmg.2024.03.008","journal-title":"JACC Cardiovasc Imaging"},{"issue":"8","key":"10660_CR19","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1016\/j.echo.2022.03.008","volume":"35","author":"J Stassen","year":"2022","unstructured":"Stassen J, Pio SM, Ewe SH et al (2022) Left Ventricular Global Longitudinal Strain in Patients with Moderate Aortic Stenosis. J Am Soc Echocardiogr 35(8):791\u2013800e4 (In eng). https:\/\/doi.org\/10.1016\/j.echo.2022.03.008","journal-title":"J Am Soc Echocardiogr"},{"issue":"8","key":"10660_CR20","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1093\/ehjci\/jex189","volume":"19","author":"ACT Ng","year":"2018","unstructured":"Ng ACT, Prihadi EA, Antoni ML et al (2018) Left ventricular global longitudinal strain is predictive of all-cause mortality independent of aortic stenosis severity and ejection fraction. Eur Heart J Cardiovasc Imaging 19(8):859\u2013867 (In eng). https:\/\/doi.org\/10.1093\/ehjci\/jex189","journal-title":"Eur Heart J Cardiovasc Imaging"},{"issue":"7","key":"10660_CR21","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1016\/j.jcmg.2021.01.020","volume":"14","author":"Y Saijo","year":"2021","unstructured":"Saijo Y, Isaza N, Conic JZ et al (2021) Left Ventricular Longitudinal Strain in Characterization and Outcome Assessment of Mixed Aortic Valve Disease Phenotypes. JACC Cardiovasc Imaging 14(7):1324\u20131334 (In eng). https:\/\/doi.org\/10.1016\/j.jcmg.2021.01.020","journal-title":"JACC Cardiovasc Imaging"},{"issue":"3","key":"10660_CR22","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1056\/NEJMoa2405880","volume":"392","author":"P G\u00e9n\u00e9reux","year":"2025","unstructured":"G\u00e9n\u00e9reux P, Schwartz A, Oldemeyer JB et al (2025) Transcatheter Aortic-Valve Replacement for Asymptomatic Severe Aortic Stenosis. N Engl J Med 392(3):217\u2013227 (In eng). https:\/\/doi.org\/10.1056\/NEJMoa2405880","journal-title":"N Engl J Med"},{"issue":"9","key":"10660_CR23","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1016\/j.jacc.2024.10.070","volume":"85","author":"NM Van Mieghem","year":"2025","unstructured":"Van Mieghem NM, Elmariah S, Spitzer E et al (2025) Transcatheter Aortic Valve Replacement in Patients With Systolic Heart Failure and Moderate Aortic Stenosis: TAVR UNLOAD. J Am Coll Cardiol 85(9):878\u2013890 (In eng). https:\/\/doi.org\/10.1016\/j.jacc.2024.10.070","journal-title":"J Am Coll Cardiol"},{"issue":"14","key":"10660_CR24","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1056\/NEJMoa2500366","volume":"392","author":"S Raposeiras-Roubin","year":"2025","unstructured":"Raposeiras-Roubin S, Amat-Santos IJ, Rossello X et al (2025) Dapagliflozin in Patients Undergoing Transcatheter Aortic-Valve Implantation. N Engl J Med 392(14):1396\u20131405 (In eng). https:\/\/doi.org\/10.1056\/NEJMoa2500366","journal-title":"N Engl J Med"},{"issue":"19","key":"10660_CR25","doi-asserted-by":"publisher","first-page":"e035460","DOI":"10.1161\/jaha.124.035460","volume":"13","author":"IJ Amat-Santos","year":"2024","unstructured":"Amat-Santos IJ, L\u00f3pez-Otero D, Nombela-Franco L et al (2024) Ramipril After Transcatheter Aortic Valve Implantation in Patients Without Reduced Ejection Fraction: The RASTAVI Randomized Clinical Trial. J Am Heart Assoc 13(19):e035460 (In eng). https:\/\/doi.org\/10.1161\/jaha.124.035460","journal-title":"J Am Heart Assoc"},{"issue":"17","key":"10660_CR26","doi-asserted-by":"publisher","first-page":"2054","DOI":"10.1016\/j.jcin.2024.06.022","volume":"17","author":"K Halavina","year":"2024","unstructured":"Halavina K, Koschutnik M, Don\u00e0 C et al (2024) Management of Fluid Overload in Patients With Severe Aortic Stenosis (EASE-TAVR): A Randomized Controlled Trial. JACC Cardiovasc Interv 17(17):2054\u20132066 (In eng). https:\/\/doi.org\/10.1016\/j.jcin.2024.06.022","journal-title":"JACC Cardiovasc Interv"},{"issue":"5","key":"10660_CR27","doi-asserted-by":"publisher","first-page":"102705","DOI":"10.1016\/j.jacadv.2026.102705","volume":"5","author":"M Autherith","year":"2026","unstructured":"Autherith M, Halavina K, Hauptmann L et al (2026) Long-Term Outcomes of Targeted Volume Overload Management in Patients With Severe Aortic Stenosis. JACC Adv 5(5):102705 (In eng). https:\/\/doi.org\/10.1016\/j.jacadv.2026.102705","journal-title":"JACC Adv"},{"issue":"12","key":"10660_CR28","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1093\/ehjci\/jeaf264","volume":"26","author":"GD Thornton","year":"2025","unstructured":"Thornton GD, McKenna M, Bennett JB et al (2025) Myocardial remodelling in aortic regurgitation: time to think beyond volumes and function? Eur Heart J - Cardiovasc Imaging 26(12):1829\u20131839. https:\/\/doi.org\/10.1093\/ehjci\/jeaf264","journal-title":"Eur Heart J - Cardiovasc Imaging"},{"issue":"11","key":"10660_CR29","doi-asserted-by":"publisher","first-page":"2170","DOI":"10.1016\/j.jcmg.2021.04.028","volume":"14","author":"A Senapati","year":"2021","unstructured":"Senapati A, Malahfji M, Debs D et al (2021) Regional Replacement and Diffuse Interstitial Fibrosis in Aortic Regurgitation: Prognostic Implications From Cardiac Magnetic Resonance. JACC Cardiovasc Imaging 14(11):2170\u20132182 (In eng). https:\/\/doi.org\/10.1016\/j.jcmg.2021.04.028","journal-title":"JACC Cardiovasc Imaging"},{"issue":"10","key":"10660_CR30","doi-asserted-by":"publisher","first-page":"1730","DOI":"10.1016\/j.jcmg.2022.05.006","volume":"15","author":"P Vejpongsa","year":"2022","unstructured":"Vejpongsa P, Xu J, Quinones MA, Shah DJ, Zoghbi WA (2022) Differences in Cardiac Remodeling in Left-Sided Valvular Regurgitation: Implications for Optimal Definition of Significant Aortic Regurgitation. JACC Cardiovasc Imaging 15(10):1730\u20131741 (In eng). https:\/\/doi.org\/10.1016\/j.jcmg.2022.05.006","journal-title":"JACC Cardiovasc Imaging"},{"issue":"2","key":"10660_CR31","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1161\/circulationaha.117.029858","volume":"137","author":"JKT Lee","year":"2018","unstructured":"Lee JKT, Franzone A, Lanz J et al (2018) Early Detection of Subclinical Myocardial Damage in Chronic Aortic Regurgitation and Strategies for Timely Treatment of Asymptomatic Patients. Circulation 137(2):184\u2013196 (In eng). https:\/\/doi.org\/10.1161\/circulationaha.117.029858","journal-title":"Circulation"},{"issue":"5","key":"10660_CR32","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/j.jcmg.2017.02.016","volume":"11","author":"A Alashi","year":"2018","unstructured":"Alashi A, Mentias A, Abdallah A et al (2018) Incremental Prognostic Utility of Left Ventricular Global Longitudinal Strain in Asymptomatic Patients With Significant Chronic Aortic Regurgitation and Preserved Left Ventricular Ejection Fraction. JACC Cardiovasc Imaging 11(5):673\u2013682 (In eng). https:\/\/doi.org\/10.1016\/j.jcmg.2017.02.016","journal-title":"JACC Cardiovasc Imaging"},{"issue":"19","key":"10660_CR33","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.1016\/j.jacc.2023.03.001","volume":"81","author":"M Malahfji","year":"2023","unstructured":"Malahfji M, Crudo V, Kaolawanich Y et al (2023) Influence of Cardiac Remodeling on Clinical Outcomes in Patients With Aortic Regurgitation. J Am Coll Cardiol 81(19):1885\u20131898 (In eng). https:\/\/doi.org\/10.1016\/j.jacc.2023.03.001","journal-title":"J Am Coll Cardiol"},{"issue":"10","key":"10660_CR34","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1016\/j.jcmg.2025.04.010","volume":"18","author":"M Malahfji","year":"2025","unstructured":"Malahfji M, Nguyen DT, Bhugra P et al (2025) Staging of Cardiac Adverse Remodeling in Moderate or Severe Aortic Regurgitation. JACC Cardiovasc Imaging 18(10):1093\u20131103 (In eng). https:\/\/doi.org\/10.1016\/j.jcmg.2025.04.010","journal-title":"JACC Cardiovasc Imaging"},{"issue":"36","key":"10660_CR35","doi-asserted-by":"publisher","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","volume":"42","author":"TA McDonagh","year":"2021","unstructured":"McDonagh TA, Metra M, Adamo M et al (2021) 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J 42(36):3599\u20133726 (In eng). https:\/\/doi.org\/10.1093\/eurheartj\/ehab368","journal-title":"Eur Heart J"},{"issue":"5","key":"10660_CR36","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.jacc.2008.02.084","volume":"52","author":"BA Carabello","year":"2008","unstructured":"Carabello BA (2008) The current therapy for mitral regurgitation. J Am Coll Cardiol 52(5):319\u2013326 (In eng). https:\/\/doi.org\/10.1016\/j.jacc.2008.02.084","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"10660_CR37","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.jcmg.2018.11.006","volume":"12","author":"PA Grayburn","year":"2019","unstructured":"Grayburn PA, Sannino A, Packer M (2019) Proportionate and Disproportionate Functional Mitral Regurgitation: A New Conceptual Framework That Reconciles the Results of the MITRA-FR and COAPT Trials. JACC Cardiovasc Imaging 12(2):353\u2013362 (In eng). https:\/\/doi.org\/10.1016\/j.jcmg.2018.11.006","journal-title":"JACC Cardiovasc Imaging"},{"issue":"19","key":"10660_CR38","doi-asserted-by":"publisher","first-page":"2465","DOI":"10.1016\/j.jacc.2019.02.061","volume":"73","author":"S Deferm","year":"2019","unstructured":"Deferm S, Bertrand PB, Verbrugge FH et al (2019) Atrial Functional Mitral Regurgitation: JACC Review Topic of the Week. J Am Coll Cardiol 73(19):2465\u20132476 (In eng). https:\/\/doi.org\/10.1016\/j.jacc.2019.02.061","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"10660_CR39","doi-asserted-by":"publisher","first-page":"e017872","DOI":"10.1161\/circimaging.124.017872","volume":"18","author":"S Koschatko","year":"2025","unstructured":"Koschatko S, Heitzinger G, Pavo N et al (2025) Left Atrial to Left Ventricular Volume Ratio in Patients With Severe Functional Mitral Regurgitation. Circ Cardiovasc Imaging 18(7):e017872 (In eng). https:\/\/doi.org\/10.1161\/circimaging.124.017872","journal-title":"Circ Cardiovasc Imaging"},{"key":"10660_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2026.01.057","author":"S Koschatko","year":"2026","unstructured":"Koschatko S, Heitzinger G, Jantsch C et al (2026) Atrial Functional Mitral Regurgitation: Effect of Phenotype Definition on Classification, Valve Features, and Prognosis. J Am Coll Cardiol. (In eng) https:\/\/doi.org\/10.1016\/j.jacc.2026.01.057","journal-title":"J Am Coll Cardiol"},{"issue":"9672","key":"10660_CR41","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1016\/s0140-6736(09)60692-9","volume":"373","author":"M Enriquez-Sarano","year":"2009","unstructured":"Enriquez-Sarano M, Akins CW, Vahanian A (2009) Mitral regurgitation. Lancet 373(9672):1382\u20131394 (In eng). https:\/\/doi.org\/10.1016\/s0140-6736(09)60692-9","journal-title":"Lancet"},{"issue":"22","key":"10660_CR42","doi-asserted-by":"publisher","first-page":"2298","DOI":"10.1161\/circulationaha.107.755942","volume":"118","author":"WH Gaasch","year":"2008","unstructured":"Gaasch WH, Meyer TE (2008) Left ventricular response to mitral regurgitation: implications for management. Circulation 118(22):2298\u20132303 (In eng). https:\/\/doi.org\/10.1161\/circulationaha.107.755942","journal-title":"Circulation"},{"issue":"10","key":"10660_CR43","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1093\/europace\/euw161","volume":"18","author":"A Goette","year":"2016","unstructured":"Goette A, Kalman JM, Aguinaga L et al (2016) EHRA\/HRS\/APHRS\/SOLAECE expert consensus on atrial cardiomyopathies: definition, characterization, and clinical implication. Europace 18(10):1455\u20131490 (In eng). https:\/\/doi.org\/10.1093\/europace\/euw161","journal-title":"Europace"},{"key":"10660_CR44","doi-asserted-by":"publisher","unstructured":"Moln\u00e1r A, S\u00e1nta A, P\u00e1sztor DT, Merkely B (2023) Atrial Cardiomyopathy in Valvular Heart Disease: From Molecular Biology to Clinical Perspectives. Cells 12(13) (In eng). https:\/\/doi.org\/10.3390\/cells12131796","DOI":"10.3390\/cells12131796"},{"issue":"12","key":"10660_CR45","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1016\/j.jacc.2015.02.009","volume":"65","author":"AW Asgar","year":"2015","unstructured":"Asgar AW, Mack MJ, Stone GW (2015) Secondary mitral regurgitation in heart failure: pathophysiology, prognosis, and therapeutic considerations. J Am Coll Cardiol 65(12):1231\u20131248 (In eng). https:\/\/doi.org\/10.1016\/j.jacc.2015.02.009","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"10660_CR46","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1093\/eurheartj\/ehx402","volume":"39","author":"G Goliasch","year":"2018","unstructured":"Goliasch G, Bartko PE, Pavo N et al (2018) Refining the prognostic impact of functional mitral regurgitation in chronic heart failure. Eur Heart J 39(1):39\u201346 (In eng). https:\/\/doi.org\/10.1093\/eurheartj\/ehx402","journal-title":"Eur Heart J"},{"issue":"7","key":"10660_CR47","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1093\/ehjci\/jet105","volume":"14","author":"P Lancellotti","year":"2013","unstructured":"Lancellotti P, Tribouilloy C, Hagendorff A et al (2013) Recommendations for the echocardiographic assessment of native valvular regurgitation: an executive summary from the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging 14(7):611\u2013644 (In eng). https:\/\/doi.org\/10.1093\/ehjci\/jet105","journal-title":"Eur Heart J Cardiovasc Imaging"},{"issue":"4","key":"10660_CR48","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.echo.2017.01.007","volume":"30","author":"WA Zoghbi","year":"2017","unstructured":"Zoghbi WA, Adams D, Bonow RO et al (2017) Recommendations for Noninvasive Evaluation of Native Valvular Regurgitation: A Report from the American Society of Echocardiography Developed in Collaboration with the Society for Cardiovascular Magnetic Resonance. J Am Soc Echocardiogr 30(4):303\u2013371 (In eng). https:\/\/doi.org\/10.1016\/j.echo.2017.01.007","journal-title":"J Am Soc Echocardiogr"},{"issue":"2","key":"10660_CR49","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1007\/s10741-022-10265-3","volume":"28","author":"H Ueyama","year":"2023","unstructured":"Ueyama H, Kuno T, Takagi H et al (2023) Prognostic value of left ventricular global longitudinal strain in mitral regurgitation: a systematic review. Heart Fail Rev 28(2):465\u2013483 (In eng). https:\/\/doi.org\/10.1007\/s10741-022-10265-3","journal-title":"Heart Fail Rev"},{"issue":"1","key":"10660_CR50","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s10554-017-1195-y","volume":"34","author":"T Podlesnikar","year":"2018","unstructured":"Podlesnikar T, Delgado V, Bax JJ (2018) Cardiovascular magnetic resonance imaging to assess myocardial fibrosis in valvular heart disease. Int J Cardiovasc Imaging 34(1):97\u2013112 (In eng). https:\/\/doi.org\/10.1007\/s10554-017-1195-y","journal-title":"Int J Cardiovasc Imaging"},{"issue":"4","key":"10660_CR51","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/j.jacc.2020.11.035","volume":"77","author":"CM Otto","year":"2021","unstructured":"Otto CM, Nishimura RA, Bonow RO et al (2021) 2020 ACC\/AHA Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary: A Report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol 77(4):450\u2013500 (In eng). https:\/\/doi.org\/10.1016\/j.jacc.2020.11.035","journal-title":"J Am Coll Cardiol"},{"issue":"15","key":"10660_CR52","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1056\/NEJMoa050496","volume":"352","author":"JG Cleland","year":"2005","unstructured":"Cleland JG, Daubert JC, Erdmann E et al (2005) The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 352(15):1539\u20131549 (In eng). https:\/\/doi.org\/10.1056\/NEJMoa050496","journal-title":"N Engl J Med"},{"issue":"7","key":"10660_CR53","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1161\/circulationaha.108.793273","volume":"119","author":"IS Anand","year":"2009","unstructured":"Anand IS, Carson P, Galle E et al (2009) Cardiac resynchronization therapy reduces the risk of hospitalizations in patients with advanced heart failure: results from the Comparison of Medical Therapy, Pacing and Defibrillation in Heart Failure (COMPANION) trial. Circulation 119(7):969\u2013977 (In eng). https:\/\/doi.org\/10.1161\/circulationaha.108.793273","journal-title":"Circulation"},{"issue":"14","key":"10660_CR54","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1056\/NEJMoa0906431","volume":"361","author":"AJ Moss","year":"2009","unstructured":"Moss AJ, Hall WJ, Cannom DS et al (2009) Cardiac-resynchronization therapy for the prevention of heart-failure events. N Engl J Med 361(14):1329\u20131338 (In eng). https:\/\/doi.org\/10.1056\/NEJMoa0906431","journal-title":"N Engl J Med"},{"issue":"15","key":"10660_CR55","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1056\/NEJMoa1009355","volume":"364","author":"T Feldman","year":"2011","unstructured":"Feldman T, Foster E, Glower DD et al (2011) Percutaneous repair or surgery for mitral regurgitation. N Engl J Med 364(15):1395\u20131406 (In eng). https:\/\/doi.org\/10.1056\/NEJMoa1009355","journal-title":"N Engl J Med"},{"issue":"24","key":"10660_CR56","doi-asserted-by":"publisher","first-page":"2297","DOI":"10.1056\/NEJMoa1805374","volume":"379","author":"JF Obadia","year":"2018","unstructured":"Obadia JF, Messika-Zeitoun D, Leurent G et al (2018) Percutaneous Repair or Medical Treatment for Secondary Mitral Regurgitation. N Engl J Med 379(24):2297\u20132306 (In eng). https:\/\/doi.org\/10.1056\/NEJMoa1805374","journal-title":"N Engl J Med"},{"issue":"22","key":"10660_CR57","doi-asserted-by":"publisher","first-page":"2037","DOI":"10.1056\/NEJMoa2300213","volume":"388","author":"GW Stone","year":"2023","unstructured":"Stone GW, Abraham WT, Lindenfeld J et al (2023) Five-Year Follow-up after Transcatheter Repair of Secondary Mitral Regurgitation. N Engl J Med 388(22):2037\u20132048 (In eng). https:\/\/doi.org\/10.1056\/NEJMoa2300213","journal-title":"N Engl J Med"},{"issue":"20","key":"10660_CR58","doi-asserted-by":"publisher","first-page":"2506","DOI":"10.1016\/j.jacc.2019.02.075","volume":"73","author":"PE Bartko","year":"2019","unstructured":"Bartko PE, Arfsten H, Heitzinger G et al (2019) A Unifying Concept for the Quantitative Assessment of Secondary Mitral Regurgitation. J Am Coll Cardiol 73(20):2506\u20132517 (In eng). https:\/\/doi.org\/10.1016\/j.jacc.2019.02.075","journal-title":"J Am Coll Cardiol"},{"issue":"19","key":"10660_CR59","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.1056\/NEJMoa2314328","volume":"391","author":"SD Anker","year":"2024","unstructured":"Anker SD, Friede T, Bardeleben R-S et al (2024) Transcatheter Valve Repair in Heart Failure with Moderate to Severe Mitral Regurgitation. N Engl J Med 391(19):1799\u20131809. https:\/\/doi.org\/10.1056\/NEJMoa2314328","journal-title":"N Engl J Med"},{"issue":"3","key":"10660_CR60","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1161\/circulationaha.104.532498","volume":"112","author":"BA Carabello","year":"2005","unstructured":"Carabello BA (2005) Modern management of mitral stenosis. Circulation 112(3):432\u2013437 (In eng). https:\/\/doi.org\/10.1161\/circulationaha.104.532498","journal-title":"Circulation"},{"issue":"11","key":"10660_CR61","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1016\/j.jcmg.2016.09.001","volume":"9","author":"MF Eleid","year":"2016","unstructured":"Eleid MF, Foley TA, Said SM, Pislaru SV, Rihal CS (2016) Severe Mitral Annular Calcification: Multimodality Imaging for Therapeutic Strategies and Interventions. JACC Cardiovasc Imaging 9(11):1318\u20131337 (In eng). https:\/\/doi.org\/10.1016\/j.jcmg.2016.09.001","journal-title":"JACC Cardiovasc Imaging"},{"issue":"5","key":"10660_CR62","doi-asserted-by":"publisher","first-page":"350","DOI":"10.5090\/kjtcs.2016.49.5.350","volume":"49","author":"KJ Park","year":"2016","unstructured":"Park KJ, Woo JS, Park JY, Jung JH (2016) Clinical Effect of Left Ventricular Dysfunction in Patients with Mitral Stenosis after Mitral Valve Replacement. Korean J Thorac Cardiovasc Surg 49(5):350\u2013355 (In eng). https:\/\/doi.org\/10.5090\/kjtcs.2016.49.5.350","journal-title":"Korean J Thorac Cardiovasc Surg"},{"issue":"1","key":"10660_CR63","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.echo.2008.11.029","volume":"22","author":"H Baumgartner","year":"2009","unstructured":"Baumgartner H, Hung J, Bermejo J et al (2009) Echocardiographic assessment of valve stenosis: EAE\/ASE recommendations for clinical practice. J Am Soc Echocardiogr 22(1):1\u201323 quiz 101-2. (In eng). https:\/\/doi.org\/10.1016\/j.echo.2008.11.029","journal-title":"J Am Soc Echocardiogr"},{"issue":"10","key":"10660_CR64","doi-asserted-by":"publisher","first-page":"e016302","DOI":"10.1161\/circimaging.123.016302","volume":"17","author":"YJ Choi","year":"2024","unstructured":"Choi YJ, Choi JY, Lee J et al (2024) Prognostic Value of Pulmonary Artery Systolic Pressure in Severe Rheumatic Mitral Stenosis. Circ Cardiovasc Imaging 17(10):e016302 (In eng). https:\/\/doi.org\/10.1161\/circimaging.123.016302","journal-title":"Circ Cardiovasc Imaging"},{"issue":"5","key":"10660_CR65","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1016\/j.echo.2021.12.010","volume":"35","author":"J Stassen","year":"2022","unstructured":"Stassen J, Butcher SC, Namazi F, Ajmone Marsan N, Bax JJ, Delgado V (2022) Left Atrial Deformation Imaging and Atrial Fibrillation in Patients with Rheumatic Mitral Stenosis. J Am Soc Echocardiogr 35(5):486\u2013494e2 (In eng). https:\/\/doi.org\/10.1016\/j.echo.2021.12.010","journal-title":"J Am Soc Echocardiogr"},{"issue":"5","key":"10660_CR66","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/j.echo.2015.12.012","volume":"29","author":"I Pasca","year":"2016","unstructured":"Pasca I, Dang P, Tyagi G, Pai RG (2016) Survival in Patients with Degenerative Mitral Stenosis: Results from a Large Retrospective Cohort Study. J Am Soc Echocardiogr 29(5):461\u2013469 (In eng). https:\/\/doi.org\/10.1016\/j.echo.2015.12.012","journal-title":"J Am Soc Echocardiogr"},{"issue":"5","key":"10660_CR67","doi-asserted-by":"publisher","first-page":"e35","DOI":"10.1161\/cir.0000000000000932","volume":"143","author":"CM Otto","year":"2021","unstructured":"Otto CM, Nishimura RA, Bonow RO et al (2021) 2020 ACC\/AHA Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary: A Report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation 143(5):e35\u2013e71 (In eng). https:\/\/doi.org\/10.1161\/cir.0000000000000932","journal-title":"Circulation"},{"issue":"20","key":"10660_CR68","doi-asserted-by":"publisher","first-page":"1876","DOI":"10.1056\/NEJMra2216709","volume":"388","author":"RT Hahn","year":"2023","unstructured":"Hahn RT, Tricuspid Regurgitation (2023) N Engl J Med 388(20):1876\u20131891 (In eng). https:\/\/doi.org\/10.1056\/NEJMra2216709","journal-title":"N Engl J Med"},{"issue":"5","key":"10660_CR69","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1093\/eurheartj\/ehy641","volume":"40","author":"N Wang","year":"2019","unstructured":"Wang N, Fulcher J, Abeysuriya N et al (2019) Tricuspid regurgitation is associated with increased mortality independent of pulmonary pressures and right heart failure: a systematic review and meta-analysis. Eur Heart J 40(5):476\u2013484 (In eng). https:\/\/doi.org\/10.1093\/eurheartj\/ehy641","journal-title":"Eur Heart J"},{"issue":"3","key":"10660_CR70","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.jcmg.2018.09.027","volume":"12","author":"EA Prihadi","year":"2019","unstructured":"Prihadi EA, Delgado V, Leon MB, Enriquez-Sarano M, Topilsky Y, Bax JJ (2019) Morphologic Types of Tricuspid Regurgitation: Characteristics and Prognostic Implications. JACC Cardiovasc Imaging 12(3):491\u2013499 (In eng). https:\/\/doi.org\/10.1016\/j.jcmg.2018.09.027","journal-title":"JACC Cardiovasc Imaging"},{"issue":"1","key":"10660_CR71","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1002\/ejhf.3106","volume":"26","author":"M Adamo","year":"2024","unstructured":"Adamo M, Chioncel O, Pagnesi M et al (2024) Epidemiology, pathophysiology, diagnosis and management of chronic right-sided heart failure and tricuspid regurgitation. A clinical consensus statement of the Heart Failure Association (HFA) and the European Association of Percutaneous Cardiovascular Interventions (EAPCI) of the ESC. Eur J Heart Fail 26(1):18\u201333 (In eng). https:\/\/doi.org\/10.1002\/ejhf.3106","journal-title":"Eur J Heart Fail"},{"issue":"12 Pt 2","key":"10660_CR72","doi-asserted-by":"publisher","first-page":"102334","DOI":"10.1016\/j.jacadv.2025.102334","volume":"4","author":"C Jantsch","year":"2025","unstructured":"Jantsch C, Koschatko S, Wu T et al (2025) Right Atrial-to-Right Ventricular Area: Prognostic Value in Patients With Secondary Tricuspid Regurgitation and Heart Failure. JACC Adv 4(12 Pt 2):102334 (In eng). https:\/\/doi.org\/10.1016\/j.jacadv.2025.102334","journal-title":"JACC Adv"},{"issue":"8","key":"10660_CR73","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/j.jchf.2020.02.008","volume":"8","author":"MF Dietz","year":"2020","unstructured":"Dietz MF, Prihadi EA, van der Bijl P, Ajmone Marsan N, Delgado V, Bax JJ (2020) Prognostic Implications of Staging Right Heart Failure in Patients With Significant Secondary Tricuspid Regurgitation. JACC Heart Fail 8(8):627\u2013636 (In eng). https:\/\/doi.org\/10.1016\/j.jchf.2020.02.008","journal-title":"JACC Heart Fail"},{"issue":"45","key":"10660_CR74","doi-asserted-by":"publisher","first-page":"4304","DOI":"10.1093\/eurheartj\/ehaa643","volume":"41","author":"J Dreyfus","year":"2020","unstructured":"Dreyfus J, Flagiello M, Bazire B et al (2020) Isolated tricuspid valve surgery: impact of aetiology and clinical presentation on outcomes. Eur Heart J 41(45):4304\u20134317 (In eng). https:\/\/doi.org\/10.1093\/eurheartj\/ehaa643","journal-title":"Eur Heart J"},{"issue":"5","key":"10660_CR75","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/j.echo.2024.01.003","volume":"37","author":"M Tomaselli","year":"2024","unstructured":"Tomaselli M, Radu DN, Badano LP et al (2024) Right Atrial Remodeling and Outcome in Patients with Secondary Tricuspid Regurgitation. J Am Soc Echocardiogr 37(5):495\u2013505 (In eng). https:\/\/doi.org\/10.1016\/j.echo.2024.01.003","journal-title":"J Am Soc Echocardiogr"},{"issue":"3","key":"10660_CR76","doi-asserted-by":"publisher","first-page":"e008666","DOI":"10.1161\/circimaging.118.008666","volume":"12","author":"EA Prihadi","year":"2019","unstructured":"Prihadi EA, van der Bijl P, Dietz M et al (2019) Prognostic Implications of Right Ventricular Free Wall Longitudinal Strain in Patients With Significant Functional Tricuspid Regurgitation. Circ Cardiovasc Imaging 12(3):e008666 (In eng). https:\/\/doi.org\/10.1161\/circimaging.118.008666","journal-title":"Circ Cardiovasc Imaging"},{"issue":"6","key":"10660_CR77","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.echo.2025.01.008","volume":"38","author":"A Clement","year":"2025","unstructured":"Clement A, Tomaselli M, Badano LP et al (2025) Association With Outcome of the Regurgitant-Volume Adjusted Right Ventricular Ejection Fraction in Secondary Tricuspid Regurgitation. J Am Soc Echocardiogr 38(6):451\u2013464 (In eng). https:\/\/doi.org\/10.1016\/j.echo.2025.01.008","journal-title":"J Am Soc Echocardiogr"},{"issue":"11","key":"10660_CR78","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1016\/j.jacc.2020.07.036","volume":"76","author":"Y Zhan","year":"2020","unstructured":"Zhan Y, Debs D, Khan MA et al (2020) Natural History of Functional Tricuspid Regurgitation Quantified by Cardiovascular Magnetic Resonance. J Am Coll Cardiol 76(11):1291\u20131301 (In eng). https:\/\/doi.org\/10.1016\/j.jacc.2020.07.036","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"10660_CR79","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1016\/j.jcmg.2025.03.015","volume":"18","author":"P Villar-Calle","year":"2025","unstructured":"Villar-Calle P, Pai V, Zhang RS et al (2025) Nonischemic Septal Fibrosis in Functional Tricuspid Regurgitation Provides Incremental Stratification of Adverse Remodeling and Prognosis. JACC Cardiovasc Imaging 18(9):959\u2013969 (In eng). https:\/\/doi.org\/10.1016\/j.jcmg.2025.03.015","journal-title":"JACC Cardiovasc Imaging"},{"issue":"3","key":"10660_CR80","doi-asserted-by":"publisher","first-page":"e018988","DOI":"10.1161\/circimaging.125.018988","volume":"19","author":"P Villar-Calle","year":"2026","unstructured":"Villar-Calle P, Zhang RS, Naami E et al (2026) Hepatic Extracellular Volume Fraction by CMR: A Novel Prognostic Marker in Tricuspid Regurgitation. Circ Cardiovasc Imaging 19(3):e018988 (In eng). https:\/\/doi.org\/10.1161\/circimaging.125.018988","journal-title":"Circ Cardiovasc Imaging"},{"issue":"1","key":"10660_CR81","doi-asserted-by":"publisher","first-page":"e70106","DOI":"10.1111\/eci.70106","volume":"56","author":"K Mascherbauer","year":"2026","unstructured":"Mascherbauer K, Kronberger C, Gruber M et al (2026) Association between CMR-derived hepatic T1-time, tricuspid regurgitation and survival. Eur J Clin Invest 56(1):e70106 (In eng). https:\/\/doi.org\/10.1111\/eci.70106","journal-title":"Eur J Clin Invest"},{"issue":"8","key":"10660_CR82","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1093\/eurheartj\/ehad585","volume":"45","author":"J Dreyfus","year":"2024","unstructured":"Dreyfus J, Galloo X, Taramasso M et al (2024) TRI-SCORE and benefit of intervention in patients with severe tricuspid regurgitation. Eur Heart J 45(8):586\u2013597 (In eng). https:\/\/doi.org\/10.1093\/eurheartj\/ehad585","journal-title":"Eur Heart J"},{"issue":"4","key":"10660_CR83","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.jacc.2025.07.002","volume":"87","author":"PT O\u2019Gara","year":"2026","unstructured":"O\u2019Gara PT, Lindenfeld J, Hahn RT et al (2026) 10 Issues for the Clinician in Tricuspid Regurgitation Evaluation and Management: 2025 ACC Expert Consensus Decision Pathway: A Report of the American College of Cardiology Solution Set Oversight Committee. J Am Coll Cardiol 87(4):447\u2013486 (In eng). https:\/\/doi.org\/10.1016\/j.jacc.2025.07.002","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"10660_CR84","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1001\/jama.2024.21189","volume":"333","author":"E Donal","year":"2025","unstructured":"Donal E, Dreyfus J, Leurent G et al (2025) Transcatheter Edge-to-Edge Repair for Severe Isolated Tricuspid Regurgitation: The Tri.Fr Randomized Clinical Trial. JAMA 333(2):124\u2013132 (In eng). https:\/\/doi.org\/10.1001\/jama.2024.21189","journal-title":"JAMA"},{"issue":"2","key":"10660_CR85","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1056\/NEJMoa2401918","volume":"392","author":"RT Hahn","year":"2025","unstructured":"Hahn RT, Makkar R, Thourani VH et al (2025) Transcatheter Valve Replacement in Severe Tricuspid Regurgitation. N Engl J Med 392(2):115\u2013126 (In eng). https:\/\/doi.org\/10.1056\/NEJMoa2401918","journal-title":"N Engl J Med"},{"issue":"7","key":"10660_CR86","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/j.jacc.2024.05.006","volume":"84","author":"P Lurz","year":"2024","unstructured":"Lurz P, Rommel KP, Schmitz T et al (2024) Real-World 1-Year Results of Tricuspid Edge-to-Edge Repair From the bRIGHT Study. J Am Coll Cardiol 84(7):607\u2013616 (In eng). https:\/\/doi.org\/10.1016\/j.jacc.2024.05.006","journal-title":"J Am Coll Cardiol"},{"key":"10660_CR87","doi-asserted-by":"publisher","DOI":"10.1093\/ejhf\/xuag047","author":"JA Naser","year":"2026","unstructured":"Naser JA, Rahme SJ, Castrichini M et al (2026) Impact of contemporary guideline-directed medical therapy on secondary mitral and tricuspid regurgitation in heart failure with reduced ejection fraction. Eur J Heart Fail. https:\/\/doi.org\/10.1093\/ejhf\/xuag047","journal-title":"Eur J Heart Fail"},{"issue":"10","key":"10660_CR88","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1016\/j.jacc.2021.12.029","volume":"79","author":"L Soulat-Dufour","year":"2022","unstructured":"Soulat-Dufour L, Lang S, Addetia K et al (2022) Restoring Sinus Rhythm Reverses Cardiac Remodeling and Reduces Valvular Regurgitation in Patients With Atrial Fibrillation. J Am Coll Cardiol 79(10):951\u2013961 (In eng). https:\/\/doi.org\/10.1016\/j.jacc.2021.12.029","journal-title":"J Am Coll Cardiol"},{"issue":"11","key":"10660_CR89","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1093\/eurheartj\/ehae088","volume":"45","author":"D Muraru","year":"2024","unstructured":"Muraru D, Badano LP, Hahn RT et al (2024) Atrial secondary tricuspid regurgitation: pathophysiology, definition, diagnosis, and treatment. Eur Heart J 45(11):895\u2013911 (In eng). https:\/\/doi.org\/10.1093\/eurheartj\/ehae088","journal-title":"Eur Heart J"},{"issue":"8","key":"10660_CR90","doi-asserted-by":"publisher","first-page":"e007862","DOI":"10.1161\/CIRCIMAGING.118.007862","volume":"11","author":"P Unger","year":"2018","unstructured":"Unger P, Pibarot P, Tribouilloy C et al (2018) Multiple and Mixed Valvular Heart Diseases. Circ Cardiovasc Imaging 11(8):e007862. https:\/\/doi.org\/10.1161\/CIRCIMAGING.118.007862","journal-title":"Circ Cardiovasc Imaging"},{"issue":"7","key":"10660_CR91","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1038\/nrcardio.2016.57","volume":"13","author":"P Unger","year":"2016","unstructured":"Unger P, Clavel MA, Lindman BR, Mathieu P, Pibarot P (2016) Pathophysiology and management of multivalvular disease. Nat Rev Cardiol 13(7):429\u2013440 (In eng). https:\/\/doi.org\/10.1038\/nrcardio.2016.57","journal-title":"Nat Rev Cardiol"},{"issue":"24","key":"10660_CR92","doi-asserted-by":"publisher","first-page":"2261","DOI":"10.1093\/eurheartj\/ehaf116","volume":"46","author":"P Unger","year":"2025","unstructured":"Unger P, Galloo X, Pibarot P (2025) Mixed valvular heart disease: diagnosis and management. Eur Heart J 46(24):2261\u20132274 (In eng). https:\/\/doi.org\/10.1093\/eurheartj\/ehaf116","journal-title":"Eur Heart J"},{"issue":"1","key":"10660_CR93","doi-asserted-by":"publisher","first-page":"29","DOI":"10.31083\/j.rcm2501029","volume":"25","author":"G De Zan","year":"2024","unstructured":"De Zan G, van der Bilt IAC, Broekhuizen LN et al (2024) Non-Invasive Assessment of Multivalvular Heart Disease: A Comprehensive Review. Rev Cardiovasc Med 25(1):29 (In eng). https:\/\/doi.org\/10.31083\/j.rcm2501029","journal-title":"Rev Cardiovasc Med"},{"issue":"4","key":"10660_CR94","doi-asserted-by":"publisher","first-page":"100301","DOI":"10.1016\/j.shj.2024.100301","volume":"8","author":"C Basman","year":"2024","unstructured":"Basman C, Landers D, Dudiy Y et al (2024) Multiple Valvular Heart Disease in the Transcatheter Era: A State-of-the-Art Review. Struct Heart 8(4):100301 (In eng). https:\/\/doi.org\/10.1016\/j.shj.2024.100301","journal-title":"Struct Heart"},{"key":"10660_CR95","doi-asserted-by":"publisher","unstructured":"Duca F, Kronberger C, Willixhofer R, Bartko PE, Bergler-Klein J, Nitsche C (2023) Cardiac Amyloidosis and Valvular Heart Disease. J Clin Med 13(1) (In eng). https:\/\/doi.org\/10.3390\/jcm13010221","DOI":"10.3390\/jcm13010221"},{"issue":"1","key":"10660_CR96","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s10741-023-10350-1","volume":"29","author":"A Aimo","year":"2024","unstructured":"Aimo A, Camerini L, Fabiani I et al (2024) Valvular heart disease in patients with cardiac amyloidosis. Heart Fail Rev 29(1):65\u201377 (In eng). https:\/\/doi.org\/10.1007\/s10741-023-10350-1","journal-title":"Heart Fail Rev"},{"issue":"3","key":"10660_CR97","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.jcmg.2015.04.012","volume":"9","author":"S Longhi","year":"2016","unstructured":"Longhi S, Lorenzini M, Gagliardi C et al (2016) Coexistence of Degenerative Aortic Stenosis and Wild-Type Transthyretin-Related Cardiac Amyloidosis. JACC Cardiovasc Imaging 9(3):325\u2013327 (In eng). https:\/\/doi.org\/10.1016\/j.jcmg.2015.04.012","journal-title":"JACC Cardiovasc Imaging"},{"key":"10660_CR98","doi-asserted-by":"publisher","unstructured":"Treibel TA, Fontana M, Gilbertson JA et al (2016) Occult Transthyretin Cardiac Amyloid in Severe Calcific Aortic Stenosis: Prevalence and Prognosis in Patients Undergoing Surgical Aortic Valve Replacement. Circ Cardiovasc Imaging 9(8) (In eng). https:\/\/doi.org\/10.1161\/circimaging.116.005066","DOI":"10.1161\/circimaging.116.005066"},{"issue":"10","key":"10660_CR99","doi-asserted-by":"publisher","first-page":"1852","DOI":"10.1002\/ejhf.1756","volume":"22","author":"C Nitsche","year":"2020","unstructured":"Nitsche C, Aschauer S, Kammerlander AA et al (2020) Light-chain and transthyretin cardiac amyloidosis in severe aortic stenosis: prevalence, screening possibilities, and outcome. Eur J Heart Fail 22(10):1852\u20131862 (In eng). https:\/\/doi.org\/10.1002\/ejhf.1756","journal-title":"Eur J Heart Fail"},{"issue":"2","key":"10660_CR100","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.jacc.2020.11.006","volume":"77","author":"C Nitsche","year":"2021","unstructured":"Nitsche C, Scully PR, Patel KP et al (2021) Prevalence and Outcomes of Concomitant Aortic Stenosis and Cardiac Amyloidosis. J Am Coll Cardiol 77(2):128\u2013139 (In eng). https:\/\/doi.org\/10.1016\/j.jacc.2020.11.006","journal-title":"J Am Coll Cardiol"},{"key":"10660_CR101","doi-asserted-by":"publisher","first-page":"134135","DOI":"10.1016\/j.ijcard.2025.134135","volume":"449","author":"KP Patel","year":"2026","unstructured":"Patel KP, Autherith M, Scully PR et al (2026) Long-term outcomes in patients with aortic stenosis and transthyretin cardiac amyloidosis. Int J Cardiol 449:134135 (In eng). https:\/\/doi.org\/10.1016\/j.ijcard.2025.134135","journal-title":"Int J Cardiol"},{"issue":"3","key":"10660_CR102","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/j.jcmg.2025.09.019","volume":"19","author":"M Serenelli","year":"2026","unstructured":"Serenelli M, Cimaglia P, Porcari A et al (2026) Analysis of Calcium Scores in Severe Aortic Stenosis Patients With and Without Cardiac Amyloidosis: The CAUSATIVE Study. JACC Cardiovasc Imaging 19(3):439\u2013441 (In eng). https:\/\/doi.org\/10.1016\/j.jcmg.2025.09.019","journal-title":"JACC Cardiovasc Imaging"},{"key":"10660_CR103","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehaf362","author":"C Nitsche","year":"2025","unstructured":"Nitsche C, Dobner S, Rosenblum HR et al (2025) Cardiac transthyretin amyloidosis treatment improves outcomes after aortic valve replacement for severe stenosis. Eur Heart J. https:\/\/doi.org\/10.1093\/eurheartj\/ehaf362","journal-title":"Eur Heart J"},{"issue":"9","key":"10660_CR104","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.1002\/ejhf.2606","volume":"24","author":"L Chacko","year":"2022","unstructured":"Chacko L, Karia N, Venneri L et al (2022) Progression of echocardiographic parameters and prognosis in transthyretin cardiac amyloidosis. Eur J Heart Fail 24(9):1700\u20131712 (In eng). https:\/\/doi.org\/10.1002\/ejhf.2606","journal-title":"Eur J Heart Fail"},{"key":"10660_CR105","unstructured":"Hauptmann L, Kronberger C, Schwarting SK et al (2025) Definition and Prognosis of Mitral Regurgitation in Transthyretin Amyloid Cardiomyopathy: An International Multicentre Cohort Study. EACVI. Vienna, Austria2025"},{"issue":"7","key":"10660_CR106","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1093\/ehjci\/jeae060","volume":"25","author":"D Tomasoni","year":"2024","unstructured":"Tomasoni D, Aimo A, Porcari A et al (2024) Prevalence and clinical outcomes of isolated or combined moderate to severe mitral and tricuspid regurgitation in patients with cardiac amyloidosis. Eur Heart J Cardiovasc Imaging 25(7):1007\u20131017 (In eng). https:\/\/doi.org\/10.1093\/ehjci\/jeae060","journal-title":"Eur Heart J Cardiovasc Imaging"},{"issue":"4","key":"10660_CR107","doi-asserted-by":"publisher","first-page":"102417","DOI":"10.1016\/j.cpcardiol.2024.102417","volume":"49","author":"I Minga","year":"2024","unstructured":"Minga I, Kwak E, Hussain K et al (2024) Prevalence of valvular heart disease in cardiac amyloidosis and impact on survival. Curr Probl Cardiol 49(4):102417 (In eng). https:\/\/doi.org\/10.1016\/j.cpcardiol.2024.102417","journal-title":"Curr Probl Cardiol"},{"issue":"17","key":"10660_CR108","doi-asserted-by":"publisher","first-page":"1748","DOI":"10.1016\/j.jcin.2022.06.009","volume":"15","author":"C Don\u00e0","year":"2022","unstructured":"Don\u00e0 C, Nitsche C, Koschutnik M et al (2022) Unveiling Cardiac Amyloidosis, its Characteristics, and Outcomes Among Patients With MR Undergoing Transcatheter Edge-to-Edge MV Repair. JACC Cardiovasc Interv 15(17):1748\u20131758 (In eng). https:\/\/doi.org\/10.1016\/j.jcin.2022.06.009","journal-title":"JACC Cardiovasc Interv"},{"issue":"8","key":"10660_CR109","doi-asserted-by":"publisher","first-page":"101998","DOI":"10.1016\/j.jacadv.2025.101998","volume":"4","author":"J Vogel","year":"2025","unstructured":"Vogel J, Luedike P, Hellhammer K et al (2025) Safety and Feasibility of Transcatheter Edge-to-Edge Repair of Mitral Regurgitation in Cardiac Amyloidosis. JACC Adv 4(8):101998 (In eng). https:\/\/doi.org\/10.1016\/j.jacadv.2025.101998","journal-title":"JACC Adv"},{"issue":"2","key":"10660_CR110","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1002\/ehf2.14262","volume":"10","author":"IA Hoerbrand","year":"2023","unstructured":"Hoerbrand IA, Volz MJ, Aus dem Siepen F et al (2023) Initial experience with transcatheter tricuspid valve repair in patients with cardiac amyloidosis. ESC Heart Fail 10(2):1003\u20131012 (In eng). https:\/\/doi.org\/10.1002\/ehf2.14262","journal-title":"ESC Heart Fail"},{"issue":"6 Pt 2","key":"10660_CR111","doi-asserted-by":"publisher","first-page":"103414","DOI":"10.1016\/j.jaccas.2025.103414","volume":"30","author":"SK Schwarting","year":"2025","unstructured":"Schwarting SK, Stolz L, Novotny J, Massberg S, N\u00e4bauer M, Hausleiter J (2025) Transcatheter Tricuspid Valve Edge-to-Edge Repair in Cardiac Wild-Type Transthyretin Amyloidosis. JACC Case Rep 30(6 Pt 2):103414 (In eng). https:\/\/doi.org\/10.1016\/j.jaccas.2025.103414","journal-title":"JACC Case Rep"},{"key":"10660_CR112","doi-asserted-by":"publisher","DOI":"10.1016\/j.cardfail.2025.08.002","author":"M Autherith","year":"2025","unstructured":"Autherith M, Hauptmann L, Koschatko S et al (2025) Amyloid-specific medication in transthyretin amyloid cardiomyopathy: a systematic review and meta-analysis of cardiovascular outcome trials. J Card Fail. (In eng) https:\/\/doi.org\/10.1016\/j.cardfail.2025.08.002","journal-title":"J Card Fail"}],"container-title":["Heart Failure Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10741-026-10660-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10741-026-10660-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10741-026-10660-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T18:20:33Z","timestamp":1785522033000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10741-026-10660-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,30]]},"references-count":112,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["10660"],"URL":"https:\/\/doi.org\/10.1007\/s10741-026-10660-0","relation":{},"ISSN":["1573-7322"],"issn-type":[{"value":"1573-7322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,30]]},"assertion":[{"value":"30 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 July 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"C.N. reports speaker\/consulting honoraria from Pfizer, Bayer, Alnylam, Prothena, B\u00f6hringer Ingelheim, and Meril Life Sciences and research contracts with Pfizer, Bayer, AstraZeneca, the Austrian Society of Cardiology, the European Association of Cardiovascular Imaging, and the Austrian Science Fund.","order":2,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"89"}}